ImmuCell Corporation Share Price & Technical Analysis
ICCC · $10.57 (+4.45%)
Healthcare / Biotechnology
$10.57
+4.45%
ImmuCell Corporation, an animal health company, develops, manufactures, and sells products that improves the health and productivity of dairy and beef cattle in the United States and internationally. It operates through two segments, Scours and Mastitis. The company offers First Defense, an orally delivered scours preventive product for calves with claims against E. coli, coronavirus, and rotaviru…
Price chart
Seasonality
May has 2 positive and 3 negative years (last 5 years shown)
19% return in May, 0% avg return in past 3 year May month.
50% return in 2026, 12% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -2% | 8% | -6% | 31% | 19% | – | – | – | – | – | – | – | 50% |
| 25 | 6% | 8% | -6% | 6% | 19% | 8% | -7% | 3% | -2% | -3% | -23% | 27% | 35% |
| 24 | 8% | 4% | 0% | -6% | -18% | 9% | -9% | -10% | -3% | -3% | 14% | 27% | 14% |
| 23 | 14% | -20% | -12% | -4% | -2% | 4% | 4% | -15% | 15% | 0% | -12% | 13% | -14% |
| 22 | -1% | 1% | 14% | 1% | -16% | 6% | 4% | -17% | 3% | 7% | -9% | -12% | -20% |
Monthly return % by calendar month · historical pattern, not a forecast
Strong Momentum · Strong · Strong
ImmuCell Corporation, an animal health company, develops, manufactures, and sells products that improves the health and productivity of dairy and beef cattle in the United States and internationally. It operates through two segments, Scours and Mastitis. The company offers First Defense, an orally delivered scours preventive product for calves with claims against E. coli, coronavirus, and rotavirus; and Tri-Shield First Defense, a passive antibody product for the treatment of E. coli, coronavirus, and rotavirus. It also provides California Mastitis Test, a quick on-farm diagnostic that is used to detect somatic cell counts in milk, as well as to determine, which quarter of the udder is mastitic; and Dual-Force First Defense, a bivalent gel tube formulation. In addition, the company developing Re-Tain Drug Product, a Nisin-based intramammary treatment of subclinical mastitis in lactating dairy cows. It sells its products through animal health distributors. ImmuCell Corporation was incorporated in 1982 and is based in Portland, Maine.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$76.08M
P/E ratio
—
52W high
$10.74
52W low
$4.52
Volume
42,483
Beta
0.51
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is ImmuCell Corporation share price today?
- ImmuCell Corporation (ICCC) last traded around $10.57 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does ICCC have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for ICCC. Download the app for real-time alerts.
- How can I analyze ImmuCell Corporation stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.